With the rapid increase in the aging population and urbanization, the prevalence of cancer has increased worldwide. The global efforts to fight cancer has become even more fierce. Although cancer therapeutics have greatly improved, there are still innumerable patients suffering from lack of efficient treatment. MDimune Inc. was founded to bring hope to many suffering patients by providing more efficient cancer therapeutics. We utilize the innovative therapeutics platform called BioDrone™ Technology, which leverages cell-derived vesicles (CDVs) obtained from various human cells to achieve highly target-specific drug delivery. We also strive to expand the BioDrone™ Technology platform to address a wide range of debilitating human diseases, such as osteoarthritis, chronic obstructive pulmonary disease (COPD), and neurodegenerative diseases.

Our vision is to develop innovative therapeutics to build a healthier and happier society. We are committed to this noble mission and hope to accomplish it by optimizing our proprietary BioDrone™ Technology platform to achieve an unprecedented accuracy for drug delivery in the body.

Thank you!